Media Coverage Mar 05 2018 Advancing Rare Disease Research Contract Pharma A record number of personalized medicines were approved by the FDA in 2017. Managing Director, Antti Nurmi, Ph.D., explains how early research provides the crucial evidence needed to conduct clinical trials. Read the full article
Media Coverage Q: What is your perspective on how the pharma industry has responded to the COVID-19 pandemic? What lessons have been learned? Learn More
